These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16472101)

  • 1. Particulate and vesicular drug carriers in the management of tuberculosis.
    Rastogi R; Sultana Y; Ali A; Aqil M
    Curr Drug Deliv; 2006 Jan; 3(1):121-8. PubMed ID: 16472101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal carriers: a rising tool for therapy of tuberculosis.
    Gupta S; Kumar P; Gupta MK; Vyas S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(4):299-53. PubMed ID: 22746187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
    Ullah Z; Athar MT; Samad A
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis: from molecular pathogenesis to effective drug carrier design.
    Dube D; Agrawal GP; Vyas SP
    Drug Discov Today; 2012 Jul; 17(13-14):760-73. PubMed ID: 22480870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis.
    Johnson CM; Pandey R; Sharma S; Khuller GK; Basaraba RJ; Orme IM; Lenaerts AJ
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4335-8. PubMed ID: 16189115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural carriers for application in tuberculosis treatment.
    Costa H; Grenha A
    J Microencapsul; 2013; 30(3):295-306. PubMed ID: 22991962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.
    Sharma A; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Dec; 24(6):599-604. PubMed ID: 15555884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-based drug delivery to alveolar macrophages.
    Vyas SP; Khatri K
    Expert Opin Drug Deliv; 2007 Mar; 4(2):95-9. PubMed ID: 17335407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting tuberculosis: old drugs, new formulations.
    Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
    Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes as drug delivery systems for the treatment of TB.
    Pinheiro M; Lúcio M; Lima JL; Reis S
    Nanomedicine (Lond); 2011 Oct; 6(8):1413-28. PubMed ID: 22026379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs.
    Pandey R; Sharma S; Khuller GK
    Indian J Exp Biol; 2004 Jun; 42(6):562-6. PubMed ID: 15260105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate-based sustained release drug delivery systems for tuberculosis.
    Ahmad Z; Khuller GK
    Expert Opin Drug Deliv; 2008 Dec; 5(12):1323-34. PubMed ID: 19040395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
    Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
    Pandey R; Zahoor A; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2003; 83(6):373-8. PubMed ID: 14623168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can nanoparticles contribute to antituberculosis therapy?
    Costa-Gouveia J; Aínsa JA; Brodin P; Lucía A
    Drug Discov Today; 2017 Mar; 22(3):600-607. PubMed ID: 28137645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.